Yuhua Li

The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study

S. Tu, Jilong Yang, Xuan Zhou, 2022, Bone Marrow Transplantation.

Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies

Xinyu Wang, S. Tu, Xin Xin, 2022, Frontiers in Immunology.

Donor-derived and off-the-shelf allogeneic anti-CD19 CAR T-cell therapy for R/R ALL and NHL: A systematic review and meta-analysis.

S. Tu, Yu Wang, Yuhua Li, 2022, Critical reviews in oncology/hematology.

Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases

S. Tu, Yuhua Li, Weixin Xie, 2016, International journal of molecular sciences.

Current state of CAR-T therapy for T-cell malignancies

S. Tu, Jilong Yang, Xuan Zhou, 2022, Therapeutic advances in hematology.

Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies

S. Tu, Xuan Zhou, Meifang Li, 2020, Biomarker Research.

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies

Yang Wang, Xuepeng Wang, Yazhuo Wang, 2023, Molecular Cancer.

Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier

Xinzhou Wu, Zhouguang Jiao, Yuhua Li, 2023, Journal of Nanobiotechnology.